Due to the different results among TNBC and non-TNBC cells as well as among TNBC subtypes, we found vague evidence, in which mechanisms caused proliferation inhibition in breast cancer cells by the PD-1/PD-L1 and ERK1/2 inhibitor. Here, CD274 is linked to breast carcinoma.